Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
April 29, 2002
- BUSINESS NEWS IN BRIEF
April 29, 2002
- Tokyo Katei Yakko Proposes New Distribution for Home Remedies
April 29, 2002
- Pharmaceutical Industry Vision Drafted by Korosho
April 22, 2002
- Takeda Puts Brakes on High Hopes for TAK-165 Anticancer Agent
April 22, 2002
- 37 New Drugs Officially Approved
April 22, 2002
- Report on Future Trends in Regenerative Medicine Completed
April 22, 2002
- Korosho Presents Bill for Rivision of PAL to Diet
April 22, 2002
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
April 22, 2002
- 1,576 Firms Apply for Disclosure of PFSB Information
April 22, 2002
- Toshiba Forms Alliance with US Heartlab to Market Cardiovascular Information System
April 22, 2002
- REGULATORY NEWS IN BRIEF
April 22, 2002
- Shimadzu Developing Next-generation DNA Sequencers
April 22, 2002
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
April 22, 2002
- MEDICAL DEVICE NEWS IN BRIEF
April 22, 2002
- Paxil's Sales Top \12 Bil. in 2001
April 22, 2002
- Meiji Seika to Promote Depromel to Non-specialists
April 22, 2002
- Hitachi Medical: Digital Ultrasound Diagnostic System
April 22, 2002
- Fujisawa Launches Protopic in Germany
April 22, 2002
- Olympus: VISERA Video System for Endoscopy
April 22, 2002
ページ
The launch of Elevidys has opened the door to gene therapy for DMD, but research into new treatments is already…
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…